首页> 美国卫生研究院文献>Infection and Immunity >Comparison of Different Live Vaccine Strategies In Vivo for Delivery of Protein Antigen or Antigen-Encoding DNA and mRNA by Virulence-Attenuated Listeria monocytogenes
【2h】

Comparison of Different Live Vaccine Strategies In Vivo for Delivery of Protein Antigen or Antigen-Encoding DNA and mRNA by Virulence-Attenuated Listeria monocytogenes

机译:病毒致弱李斯特菌单核细胞增生性蛋白递送蛋白抗原或编码抗原的DNA和mRNA的体内不同活疫苗策略的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Listeria monocytogenes can be used to deliver protein antigens or DNA and mRNA encoding such antigens directly into the cytosol of host cells because of its intracellular lifestyle. In this study, we compare the in vivo efficiencies of activation of antigen-specific CD8 and CD4 T cells when the antigen is secreted by L. monocytogenes or when antigen-encoding plasmid DNA or mRNA is released by self-destructing strains of L. monocytogenes. Infection of mice with self-destructing L. monocytogenes carriers delivering mRNA that encodes a nonsecreted form of ovalbumin (OVA) resulted in a significant OVA-specific CD8 T-cell response. In contrast, infection with L. monocytogenes delivering OVA-encoding DNA failed to generate specific T cells. Secretion of OVA by the carrier bacteria yielded the strongest immune response involving OVA-specific CD8 and CD4 T cells. In addition, we investigated the antigen delivery capacity of a self-destructing, virulence-attenuated L. monocytogenes aroA/B mutant. In contrast to the wild-type strain, this mutant exhibited only marginal liver toxicity when high doses (5 × 107 CFU per animal administered intravenously) were used, and it was also able to deliver sufficient amounts of secreted OVA into mice. Therefore, the results presented here could lay the groundwork for a rational combination of L. monocytogenes as an attenuated carrier for the delivery of protein and nucleic acid vaccines in novel vaccination strategies.
机译:单核细胞增生性李斯特菌由于其细胞内生活方式,可用于将蛋白质抗原或编码此类抗原的DNA和mRNA直接递送到宿主细胞的细胞质中。在这项研究中,我们比较了单核细胞增生李斯特菌分泌抗原或单核细胞增生李斯特氏菌自毁菌株释放抗原编码质粒DNA或mRNA时抗原特异性CD8和CD4 T细胞活化的体内效率。 。用自毁单核细胞增生李斯特氏菌载体感染的小鼠感染mRNA,该mRNA编码卵白蛋白(OVA)的非分泌形式,导致明显的OVA特异性CD8 T细胞应答。相比之下,感染单核细胞增生李斯特氏菌的病毒传递编码OVA的DNA不能产生特异性T细胞。携带细菌的OVA分泌产生了最强的免疫应答,涉及OVA特异性CD8和CD4 T细胞。此外,我们调查了自毁,毒力减弱的单核细胞增生李斯特氏菌aroA / B突变体的抗原传递能力。与野生型菌株相反,当使用高剂量(每只动物静脉注射5×10 7 CFU)时,该突变体仅表现出轻微的肝毒性,并且还能够递送足够量的将OVA分泌到小鼠体内。因此,此处提出的结果可能为单核细胞增生李斯特氏菌合理组合提供了基础,该菌株可作为新型疫苗接种策略中蛋白质和核酸疫苗递送的减毒载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号